TransCode Therapeutics, Inc.
$1.70
-0.10 (-5.56%)
Price as of Oct 16, 2026 market close
Performance
- 1 Month
- -1.2%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Largest decline max drawdown, since Aug 2026
- -55.6%
Own RNAZ?
See how RNAZ contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.